NCT03517358View on ClinicalTrials.gov

Virological Suppression in HIV Positive Patients Involved in a Novel Standardized Adherence Protocol

PHASE3CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

May 1, 2018

Study Completion Date

May 1, 2018

Conditions
Hiv
Interventions
OTHER

Service of care

Subjects will be receiving care from case management or clinical pharmacy.

Trial Locations (1)

95831

One Community Health, Sacramento

All Listed Sponsors
lead

University of California, Davis

OTHER

NCT03517358 - Virological Suppression in HIV Positive Patients Involved in a Novel Standardized Adherence Protocol | Biotech Hunter | Biotech Hunter